bioRxivImmunologyPreprint
Macrophages redeploy functional cancer cell surface proteins following phagocytosis
Regan F. VolkiD, Sara E. Casebeer, Andrew C Condon, Bahar Zirak, Nayelis A. Manon, Iryna IrkliyenkoiD, Huajun LiaoiD, Tao Shao, Tommaso PolliniiD, Vijay RamaniiD, Ajay V. MakeriD, Trevor P. FidleriD, Hani GoodarziiD, Balyn W. ZaroiD
- Citations
- 0
Abstract
Macrophage-mediated phagocytosis is a vital innate immune process altered in cancer. We show here that tumor-associated macrophages (TAMs) redeploy intact cell surface proteins from cancer cells to their own cell surface. We initially observed the canonical epithelial cancer surface marker EpCAM on the surface of TAMs in primary human solid tumors but not paired peripheral blood macrophages. In a murine model of metastatic breast cancer, we also observed EpCAM on the surface of primary TAMs that have phagocytosed breast cancer cells. In a model of a myeloproliferative neoplasm, we again found engulfed cell-derived surface proteins on the surface of macrophages following phagocytosis. A co-culture system and proteomics assay that tags proteins based on their cell-of-origin revealed hundreds of cell surface proteins synthesized in cancer cells are present and fully intact on the surface of macrophages following phagocytosis. Using a biotin transfer assay, we determined that these proteins were on the surface of the cancer cell prior to redeployment by the macrophage following phagocytosis. Furthermore, macrophages that redeploy a neutral amino acid transporter correspondingly show increased transport of an unnatural amino acid substrate. Widespread acquisition of proteins from engulfed cells may contribute to two critical TAM phenotypes: the inability to phagocytose and reprogrammed metabolism.
- organism: human
- organism: mouse
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Breast cancer spheroids prefer activated macrophages as an accomplice: An in vitro study
Abhishek Teli, Ranjani Iyer, … Tuli Dey·bioRxiv·Sep 24, 2024
- Cancer cell phagocytosis induces an anti-inflammatory gene regulatory program in macrophages
Catherine R. Zhang, Lei Xiong, … Michael Cory Bassik·bioRxiv·Aug 18, 2025
- High-motility pro-tumorigenic monocytes drive macrophage enrichment in the tumor microenvironment
Wenxuan Du, Bryan Zhou, … Denis Wirtz·bioRxiv·Jul 16, 2024
- Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial Localization
N. Ben-Chetrit, X. Niu, … D. A. Landau·bioRxiv·Oct 24, 2023
- CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia
A. ALLOUCH, L. VOISIN, … j.-l. PERFETTINI·bioRxiv·Jan 18, 2022
- CAR-MACROPHAGES ACTIVATE ANTI TUMOR T CELLS IN THE ABSENCE OF PHAGOCYTOSIS
Lea C. Feldmann, Amaury Vaysse, … Capucine L. Grandjean·bioRxiv·Aug 28, 2026